Quality Payment Program Measures Data |
Back to Merit-based Incentive Payment System |
| Measure ID | NQF ID | National Quality Strategy Domain | Title | High Priority | Measure Type | Submission Methods | Speciality Measure Sets | |
|---|---|---|---|---|---|---|---|---|
| NIPM22 | Person and Caregiver Centered Experience and Outcomes | CHANGE IN PATIENT REPORTED QUALITY OF LIFE FOLLOWING EPIDURAL CORTICOSTEROID INJECTION | Outcome | Registry | Details | |||
| NIPM23 | Person and Caregiver Centered Experience and Outcomes | CHANGE IN PATIENT REPORTED QUALITY OF LIFE FOLLOWING MAJOR JOINT CORTICOSTEROID INJECTION | Outcome | Registry | Details | |||
| NIPM24 | Person and Caregiver Centered Experience and Outcomes | CHANGE IN PATIENT REPORTED QUALITY OF LIFE FOLLOWING INTRATHECAL PUMP IMPLANTATION | Outcome | Registry | Details | |||
| NIPM25 | Person and Caregiver Centered Experience and Outcomes | CHANGE IN PATIENT REPORTED QUALITY OF LIFE FOLLOWING INTERSPINOUS INDIRECT DECOMPRESSION (SPACER) | Outcome | Registry | Details | |||
| NPQR1 | Effective Clinical Care | Notification to the ordering provider requesting myoglobin or CK-MB in the diagnosis of suspected acute myocardial infarction (AMI) | Process | Registry | Details | |||
| NPQR11 | Communication and Care Coordination | Rate of communicating results of an amended report with a major discrepancy to the responsible provider | Process | Registry | Details | |||
| NPQR13 | Communication and Care Coordination | Rate of notification to clinical provider of a new diagnosis of malignancy | Process | Registry | Details | |||
| NPQR15 | Effective Clinical Care | Non-small cell lung carcinoma (NSCLC) ancillary biomarker testing status and turnaround time (TAT) from point of specimen accession date to ancillary biomarker testing completion and reporting date should be ≤ 10 days | Process | Registry | Details | |||
| NPQR16 | Effective Clinical Care | Notification to the provider ordering repeat blood chemistry panels in clinically stable patients within four days. | Process | Registry | Details | |||
| NPQR17 | Effective Clinical Care | Notification to the provider ordering repeat C. difficile stool toxin testing within seven days | Process | Registry | Details | |||
| NPQR18 | Effective Clinical Care | Notification to the provider ordering repeat CBCs in clinically stable patients within four days | Process | Registry | Details | |||
| NPQR19 | Effective Clinical Care | Notification to the provider ordering repeat Hepatitis C serology testing on a patient with previously positive results | Process | Registry | Details | |||
| NPQR2 | Effective Clinical Care | Notification to the ordering provider requesting thyroid screening tests other than only a Thyroid Stimulating Hormone (TSH) test in the initial screening of a patient with a suspected thyroid disorder | Process | Registry | Details | |||
| NPQR3 | Effective Clinical Care | Notification to the ordering provider requesting amylase testing in the diagnosis of suspected acute pancreatitis | Process | Registry | Details | |||
| NPQR4 | Communication and Care Coordination | Time interval: critical value reporting for chemistry | Process | Registry | Details | |||
| NPQR5 | Communication and Care Coordination | Time interval: critical value reporting for cerebrospinal fluid - white blood cell (CSF - WBC) | Process | Registry | Details | |||
| NPQR6 | Communication and Care Coordination | Time interval: critical value reporting for toxicology | Process | Registry | Details | |||
| NPQR7 | Communication and Care Coordination | Time interval: critical value reporting for troponin | Process | Registry | Details | |||
| OBERD32 | Person and Caregiver Centered Experience and Outcomes | Quality of Life - Physical Health Outcomes by Oberd | Outcome | Registry | Details | |||
| OEIS6 | Effective Clinical Care | Appropriate non-invasive arterial testing for patients with intermittent claudication who are undergoing a LE peripheral vascular intervention | Process | Registry | Details |